Specific treatment | All primary care patients diagnosed with migraine % (SE) (N = 74,506) | Survey population with EHR diagnosed migraine | Survey population with diagnosed migraine corrected estimates | ||
---|---|---|---|---|---|
Respondents* % (SE) (n = 1320) | Non-respondents* % (SE) (n = 8815) | Corrected for sampling weight** % (SE) (n = 1320) | Corrected for sampling weight and response bias**,††† % (SE) (n = 1320) | ||
Acute medication orders | |||||
All acute prescription treatments | 26.4% (0.2%) | 33.3%† (1.3%) | 20.4% (0.4%) | 37.2%†† (0.5%) | 26.2% (0.2%) |
Non-narcotic analgesics | |||||
1–2 orders | 1.5% (0.1%) | 2.1%† (0.4%) | 1.4% (0.1%) | 1.6% (0.1%) | 1.6% (0.1%) |
3 + orders | 0.8% (0.09%) | 1.0%† (0.3%) | 0.7% (0.09%) | 1.0% (0.1%) | 0.8% (0.03%) |
Narcotic analgesics | |||||
1–2 orders | 1.8% (0.1%) | 3.2%† (0.5%) | 1.6% (0.1%) | 3.2%†† (0.2%) | 2.0%††† (0.05%) |
3 + orders | 1.8% (0.1%) | 2.6%† (0.4%) | 1.7% (0.1%) | 2.6%†† (0.2%) | 1.8% (0.05%) |
Triptans | |||||
1–2 orders | 14.2% (0.3%) | 20.8%† (1.1%) | 13.0% (0.4%) | 24.1%†† (0.4%) | 14.3% (0.1%) |
3 + orders | 4.1% (0.2%) | 6.6%† (0.7%) | 3.7% (0.2%) | 7.5%†† (0.3%) | 4.1% (0.08%) |
Other migraine-specific prescriptions | |||||
1–2 orders | 1.2% (0.1%) | 2.6%† (0.4%) | 1.0% (0.1%) | 2.5%†† (0.2%) | 1.1% (0.04%) |
3 + orders | 0.2% (0.04%) | 0.4%† (0.2%) | 0.2% (0.04%) | 0.4%†† (0.06%) | 0.2% (0.01%) |
Preventive medication orders | |||||
All preventive treatments | 12.0% (0.1%) | 17.1%† (1.0%) | 11.2% (0.3%) | 16.8%†† (0.4%) | 11.6% (0.1%) |
Beta blockers, any | |||||
1–2 orders | 2.3% (0.2%) | 3.1%† (0.5%) | 2.1% (0.1%) | 3.2%† (0.2%) | 2.4% (0.06%) |
3 + orders | 0.5% (0.07%) | 0.9%† (0.3%) | 0.5% (0.08%) | 0.9%†† (0.09%) | 0.5% (0.02%) |
Calcium channel blockers, any | |||||
1–2 orders | 0.9% (0.09%) | 1.6%† (0.3%) | 0.8% (0.09%) | 1.4%†† (0.1%) | 0.9% (0.03%) |
3 + orders | 0.2% (0.04%) | 0.3% (0.1%) | 0.2% (0.04%) | 0.3% (0.06%) | 0.2% (0.02%) |
Antidepressants, any | |||||
1–2 orders | 3.1% (0.2%) | 4.5%† (0.6%) | 3.0% (0.2%) | 4.9%†† (0.2%) | 3.1% (0.06%) |
3 + orders | 1.0% (0.1%) | 1.6%† (0.3%) | 0.9% (0.1%) | 1.5%†† (0.1%) | 0.9% (0.03%) |
Anticonvulsants, any | |||||
1–2 orders | 3.9% (0.2%) | 5.7%† (0.6%) | 3.6% (0.2%) | 5.1%†† (0.2%) | 3.8% (0.07%) |
3 + orders | 1.6% (0.1%) | 2.3%† (0.4%) | 1.5% (0.1%) | 2.1%†† (0.1%) | 1.5% (0.04%) |
OnabotulinumtoxinA, any | |||||
1–2 orders | 1.0% (0.1%) | 1.8%† (0.4%) | 0.9% (0.1%) | 1.6%†† (0.1%) | 0.9% (0.03%) |
3 + orders | 0.06% (0.02%) | 0.08% (0.08%) | 0.06% (0.03%) | 0.06% (0.02%) | 0.05% (0.01%) |